| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 132.005 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 144.71 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 171.032 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 141.867 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 154.001 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 178.994 | 82 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 440.881 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 429.093 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 493.353 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 393.863 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 448.701 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 548.941 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 180.382 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 249.055 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 299.076 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 191.679 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 266.891 | 86 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 325.003 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1161.34 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1257.69 | 96 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 482.956 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1031.71 | 96 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 751.855 | 94 |